How to Reconstitute Tirzepatide 15 mg: The Mass and Volume Maths

By What Peptides Editorial Team · Updated 2026-09-14 · Part of Peptide Handling Guides: Reconstitution Arithmetic, Storage and Testing

Fifteen milligrams changes one thing and only one thing about the arithmetic: the numerator. Concentration is still mass divided by volume, and the unit conversions are still the ones any other vial uses. This page exists to show how a larger stated mass plays out across common diluent volumes, why it makes some numbers easier to read and others harder, and what belongs on a label. It is educational documentation for laboratory and research materials. It is not instructions for preparing or administering anything for a human or an animal, and it is not medical advice.

Tirzepatide itself is a prescription medicine in most countries, sold as a licensed product with defined strengths and its own prescribing information. Material offered online with the same name is commonly labelled research use only, not for human consumption, and that category carries no regulatory assurance that the contents match the label. For the surrounding arithmetic see the general reconstitution guide and the same worked approach on a smaller vial.

Why a Larger Stated Mass Changes the Numbers

Three times the numerator means three times the concentration at any fixed volume. At 1.0 mL of diluent a 15 mg vial gives 15.0 mg per mL, where a 5 mg vial would give 5.0 mg per mL. At 2.0 mL it gives 7.5 mg per mL, and at 2.5 mL it gives 6.0 mg per mL. Nothing else about the operation changes. This proportionality is useful precisely because it makes errors easy to spot: any computed figure that does not scale linearly with the stated mass has been mis-entered somewhere, and searching for that linearity is a fast check on a whole column of records.

A larger numerator also shifts the trade-off between the two practical limits. Concentrated preparations mean smaller measured volumes for the same mass, and very small volumes are read less accurately against graduations, since a fixed reading error becomes a larger fraction of what is being measured. Diluting further solves that but moves toward solubility ceilings for sequences that self-associate, and it increases surface area contact relative to the amount of peptide, relevant to adsorption losses in some containers.

One more identity point applies to this compound specifically. Tirzepatide is a dual GIP and GLP-1 receptor agonist carrying a C20 fatty diacid moiety, so its molecular weight is not the sum of its amino acid residues alone. Any entry converting mass to moles must use the correct molecular weight for the salt form specified on the certificate, and must record whether that document reports free peptide or salt mass. Getting this wrong does not change the concentration arithmetic, but it will change every molar figure derived afterwards.

Converting Between Milligrams and Micrograms

The conversion is a factor of one thousand, and it is worth writing out longhand once. One milligram equals 1000 micrograms. So 15.0 mg per mL is 15,000 mcg per mL, 7.5 mg per mL is 7500 mcg per mL, and 6.0 mg per mL is 6000 mcg per mL. Applying the same relation to aliquots: at 6.0 mg per mL, a 0.10 mL portion contains 0.60 mg, which is 600 mcg, while at 15.0 mg per mL the same portion contains 1.5 mg, which is 1500 mcg.

A separate and frequently confused conversion concerns the word unit. On some labels a unit is an international unit of biological activity defined per preparation, and no universal factor turns it into milligrams. If you encounter a figure in units, the conversion must come from that product's own documentation, not from a general rule. Mixing the two silently produces numbers that look plausible and are off by amounts nobody notices until two datasets disagree in a way that cannot be reconciled.

Rounding is the last small discipline worth building into the habit. Keeping concentration to two significant figures in the record, while retaining the full precision during the calculation, prevents spurious accuracy creeping into a lab notebook. A figure presented as 6.00 mg per mL implies measurement precision that most volume reading simply does not deliver, and an analyst reading that entry later has no way to know which digits were meaningful. Write what you computed, then write what you actually believe, separately.

Aliquot Labels and the Prescription-Status Caveat

Labels fail in two ways: too little information, and information that cannot survive a freezer. Minimum viable contents are peptide name, lot number, concentration written in mg per mL, date of reconstitution and initials. Where frozen aliquots are used, write the cumulative number of freeze-thaw cycles on the tube itself. Label material also matters: many inks and adhesives detach after months at -20 degrees C, so a legible record that lifts off the tube is functionally no record at all at the moment it is needed.

Now the status caveat, stated plainly because this keyword attracts mixed expectations. Tirzepatide is a prescription medicine in most countries, supplied as a finished, licensed product. Third-party vials labelled research use only are not that product, are not held to the same standard, and carry no assurance of identity, strength, purity or sterility. Nothing here explains how to prepare a medicine, and nothing here should be read as a quantity or a frequency for any person. See why injecting non-pharmaceutical material raises sterility and regulatory questions.

Where a researcher does handle material from either source, the same documentation discipline applies, and the paperwork does most of the work. Record the source category, copy the certificate verbatim including its method statement and date, and cite any independent testing by laboratory and report identifier. If a claim cannot be traced to a batch-specific document, write unknown rather than repeating it. Our pages on what purity and identity testing actually establish and the rest of the documentation guides go further into this. We give no amounts for people, no frequency, no route of administration and no outcome claim: the table above contains illustrative arithmetic and nothing beyond it. Where a licensed medicine is involved, the only legitimate sources are its approved prescribing information, a licensed clinician and your national regulator.

• Concentration stated in mg per mL, with the mcg per mL figure on the same line.
• Lot number copied from the vial rather than from the order confirmation.
• Reconstitution date in unambiguous order, plus initials.
• Cumulative freeze-thaw count written directly on the aliquot container.
• Source category noted: licensed medicine or research-use-only material.

This page is part of the Peptide Handling Guides: Reconstitution Arithmetic, Storage and Testing guide.